Clinical features and treatment of alveolar echinococcosis

Current Opinion in Infectious Diseases

Volumn 23, Issue 5, 2010, Pages 505-512

  Kern, Peter ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Albendazole; alveolar echinococcosis; benzimidazoles; clinical case definition; Echinococcus multilocularis; interventional procedures; liver transplantation; surgery; treatment; WHO classification

Indexed keywords

ALBENDAZOLE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; BENZIMIDAZOLE DERIVATIVE; GENISTEIN; MEBENDAZOLE;

CHINA; CLINICAL FEATURE; CONSENSUS DEVELOPMENT; ECHINOCOCCOSIS; ECHINOCOCCUS MULTILOCULARIS; EUROPE; HISTOPATHOLOGY; HUMAN; LIVER TRANSPLANTATION; NUCLEIC ACID ANALYSIS; PREVALENCE; QUALITY OF LIFE; REVIEW; RURAL AREA; SERODIAGNOSIS; SWITZERLAND; URBAN AREA; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTHELMINTICS; ASIA; BENZIMIDAZOLES; CHEMOPREVENTION; ECHINOCOCCOSIS, HEPATIC; EUROPE; GENERAL SURGERY; HUMANS;

EID: 77956228087     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32833d7516     Document Type: Review

References (80)

1. Craig PS, Deshan L, Macpherson CNL, et al. A large focus of alveolar echinococcosis in central China. Lancet 1992; 340:826-831.
2. Craig PS. Echinococcus multilocularis. Curr Opin Infect Dis 2003; 16:437-444.
3. Moro P, Schantz PM. Echinococcosis: a review. Int J Infect Dis 2009; 13:125-133; Epub 2008 Oct 19.
4. Schweiger A, Ammann RW, Candinas D, et al. Human alveolar echinococcosis after fox population increase, Switzerland. Emerg Infect Dis 2007; 13:878-882.
5. Yang YR, Liu XZ, Vuitton DA, et al. Simultaneous alveolar and cystic echinococcosis of the liver. Trans RSoc Trop Med Hyg 2006; 100:597-600.
6. Yang YR, Sun T, LiZ, et al. Community surveys and riskfactor analysis of human alveolar and cystic echinococcosis in Ningxia Hui Autonomous Region, China. Bull World Health Organ 2006; 84:714-721.
7. Craig PS, Li T, Qiu J, et al. Echinococcosis and Tibetan communities [letter]. Emerg Infect Dis 2008; 14:1674-1675.
8. Yu SH, Wang H, Wu XH, et al. Cystic and alveolar echinococcosis: an epidemiological survey in a Tibetan population in southeast Qinghai, China. Jpn J Infect Dis 2008; 61:242-246.
9. Yang YR, Craig PS, Sun T, et al. Echinococcosis in Ningxia Hui Autonomous •• Region, northwest China. Trans R Soc Trop Med Hyg 2008; 102:319-328.
10. Li T, Chen X, Zhen R, et al. Widespread co-endemicity of human cystic and •• alveolar echinococcosis on the eastern Tibetan Plateau, northwest Sichuan/southeast Qing-hai, China. Acta Trop 2010; 113:248-256.
11. Zhou P, Chen N, Zhang R-L, et al. Food-borne parasitic zoonoses in China: perspective for control. Trends Parasitol 2008; 24:190-196.
12. Torgerson PR, Schweiger A, Deplazes P, et al. Alveolar echinococcosis: from a deadly disease to a well controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. J Hepatol 2008; 49:72-77.
13. Ammann RW, Eckert J. Parasitic diseases of the liver and intestine: cestodes, Echinococcus. Gastroenterol Clin North Am 1996; 25:655-689.
14. Bresson-Hadni S, Laplante JJ, Lenys D, et al. Seroepidemiologic sceening of Echinococcus multilocularis infection in an European area endemic for alveolar echinococcosis. Am J Trop Med Hyg 1994; 51:837-846.
15. Romig T, Kratzer W, Kimmig P, et al. An epidemiological survey of human alveolar echinococcosis in southwestern Germany. Am J Trop Med Hyg 1999; 61:566-573.
16. Liu YH, Wang XG, Gao JS, et al. Continuous albendazole therapy in alveolar echinococcosis: long-term follow-up observation of 20 cases. Trans R Soc Trop Med Hyg 2009; 103:768-778.
17. Kern P, Ammon A, Kron M, et al. Risk factors for alveolar echinococcosis in humans. Emerg Infect Dis 2004; 10:2088-2093.
18. Kern P, Bardonnet K, Renner E, et al. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982-2000. Emerg Infect Dis 2003; 9:343-349.
19. Jorgensen P, an Der Heiden M, Kern P, et al. Underreporting of human alveolar echinococcosis, Germany. Emerg Infect Dis 2008; 14:935-937.
20. Brunetti E, Kern P, Vuitton DA, et al. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop 2010; 114:1-16.
21. Kern P, Wen H, Sato N, et al. WHO classification of alveolar echinococcosis: principles and application. Parasitol Int 2006; 55 (Suppl.):283-287.
22. Ma L, Liu WK, Mao BY, Zhang YK. An echinococcosis multilocularis presenting as a giant anterior cranial basilar tumor. Neurol Sci 2009; 30:247-249.
23. Qu B, Liu C, Yang Y, et al. Giant hepatic alveolar echinococcosis in an adult. Am J Surg 2009; 198:e23-e24.
24. Buttenschoen K, Buttenschoen DC, Gruener B, et al. Long-term experience on surgical treatment of alveolar echinococcosis. Langenbecks Arch Surg 2009; 394:689-698.
25. Buttenschoen K, Gruener B, Buttenschoen DC, et al. Palliative operation for the treatment of alveolar echinococcosis. Langenbecks Arch Surg 2009; 394:199-204.
26. Reuter S, Nussle K, Kolokythas O, et al. Alveolar liver echinococcosis: a comparative study of three imaging techniques. Infection 2001; 29:119-125.
27. Coskun A, Ozturk M, Karahan OI, et al. Alveolar echinococcosis of the liver: correlative color Doppler US, CT, and MRI study. Acta Radiol 2004; 45:492-498.
28. Ehrhardt AR, Reuter S, Buck AK, et al. Assessment of disease activity in alveolar echinococcosis: a comparison of contrast-enhanced ultrasound, three-phase helica CT and 18-F-fluorodeoxyglucose positron-emission tomography. Abdom Imaging 2007; 32:730-736.
29. Czermak BV, Akhan O, Hiemetzberger R, et al. Echinococcosis of the liver. Abdom Imaging 2008; 33:133-143.
30. Inceboz T, Goktay Y, Sagol O, et al. Mesenteric Doppler ultrasonography findings of Echinococcus multilocularis infection: an experimental study. Turkiye Parazitol Derg 2009; 33:151-154.
31. Pawlowski Z, Eckert J, Vuitton DA, et al. Echinococcosis in humans: clinical as-pects, diagnosis and treatment. In: Manual on Echinococcosis in Humans and Animals: a Public Health Problem of Global Concern; 2001. Paris: World Organisation of Animal Health. J Eckert, M A Gemmell, F X Meslin, Z S Pawlowski, editors. pp. 20-66.
32. Tappe D, Zidowitz S, Demmer P, et al. Three-dimensional reconstruction of Echinococcus multilocularis larval growth in human hepatic tissue reveals complex growth patterns. Am J Trop Med Hyg 2010; 82:126-127.
33. Hemphill A, Stadelmann B, Scholl S, et al. Echinococcus metacestodes aslaboratory models for the screening of drugs against cestodes and trema-todes. Parasitology 2010; 137:569-587.
34. Buttenschoen K, Kern P, Reuter S, et al. Hepatic infestation of Echinococcus multilocularis with extension to regional lymph nodes. Langenbecks Arch Surg 2009; 394:699-704.
35. WHO. Guidelines for treatment of cystic and alveolar echinococcosis in humans. WHO Informal Working Group on Echinococcosis. Bull World Health Organ 1996; 74:231-242.
36. Wang J, Cai B, You C. Surgical treatment options for cerebral alveolar echinococcosis: experience in six patients. Neurol India 2009; 57:157-161.
37. Aydinli B, Aydin U, Yazici P, et al. Alveolar echinococcosis of liver presenting with neurological symptoms due to brain metastases with simultaneous lung metastasis: a case report. Turkiye Parazitol Derg 2008; 32:371-374.
38. Ozkok A, Gul E, Okumus G, et al. Disseminated alveolar echinococcosis mimicking a metastatic malignancy. Intern Med 2008; 47:1495-1497.
39. Rausch RL, Wilson JF, Schantz PM, Mcmahon BJ. Spontaneous death of Echinococcocus multilocularis: cases diagnosed serologically (by Em2 ELISA) and clinical significance. Am J Trop Med Hyg 1987; 36:576-585.
40. Gottstein B, Saucy F, Deplazes P, et al. Is high prevalence of Echinococcus multilocularis in wild and domestic animals associated with disease incidence in humans? Emerg Infect Dis 2001; 7:408-412.
41. Reuter S, Buck A, Manfras B, et al. Structured treatment interruption in patients with alveolar echinococcosis. Hepatology 2004; 39:509-517.
42. Stumpe KD, Renner-Schneiter EC, Kuenzle AK, et al. F-18-fluorodeoxyglu- cose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy. Infection 2007; 35:11-18.
43. Reuter S, Gruner B, Buck AK, et al. Long-term follow-up of metabolic activity in human alveolar echinococcosis using FDG-PET. Nuklearmedizin 2008; 47:147-152.
44. Crouzet J, Grenouillet F, Delabrousse E, et al. Personalized management of patients with inoperable alveolar echinococcosis undergoing treatment with albendazole: usefulness of positron-emission-tomography combined with serological and computed tomography follow-up. Clin Microbiol Infect 2010; 16:788-791.
45. Sailer M, Soelder B, Allerberger F, et al. Alveolar echinococcosis of the liver in a six-year-old girl with acquired immunodeficiency syndrome. J Pediatr 1997; 130:320-323.
46. Zingg W, Renner-Schneiter EC, Pauli-Magnus C, et al. Swiss HIV Cohort Study: alveolar echinococcosis of the liver in an adult with human immunodeficiency virus type-1 infection. Infection 2004; 32:299-302.
47. Chopdat N, MenezesCN, John MA, et al. A gardener who coughed up blood. Lancet 2007; 370:1520.
48. Yang YR, Gray DJ, Ellis MK, et al. Human cases of simultaneous echinococcosis and tuberculosis: significance and extent in China. Parasit Vectors 2009; 2:53.
49. Kern P. Human echinococcosis: follow-up of 23 patients treated with mebendazole. Infection 1983; 11:17-24.
50. Ammann RW, Ilitsch N, Marincek B, Freiburghaus AU. Effect of chemotherapy on the larval mass and the long-term course of alveolar echinococcosis. Hepatology 1994; 19:735-742.
51. Horton J. Albendazole for the treatment of echinococcosis. Fundam Clin Pharmacol 2003; 17:205-212.
52. Reuter S, Jensen B, Buttenschoen K, et al. Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J Antimicrob Chemother 2000; 46:451-456.
53. Bresson-Hadni S, Vuitton DA, Bartholomot B, et al. A twenty-year history of alveolar echinococcosis: analysis of a series of 117 patients from eastern France. Eur J Gastroenterol Hepatol 2000; 12:327-336.
54. Tappe D, Frosch M, Sako Y, et al. Close relationship between clinical regression and specific serology in the fol-low-up of patients with alveolar echinococcosis in different clinical stages. Am J Trop Med Hyg 2009; 80:792-797.
55. Stadelmann B, Scholl S, Mulller J, Hemphill A. Application of an in vitro drug screening assay based on the release of phosphoglucose isomerase to determine the structure-activity relationship of thiazolides against Echinococcus multilocularis metacestodes. J Antimicrob Chemother 2010; 65:512-519.
56. Spiliotis M, Brehm K. Axenic in vitro cultivation of Echinococcus multilocu-laris metacestode vesicles and the generation of primary cell cultures. In: Rupp S, Sohn K, editors. Methods in Molecular Biology: Host-Pathogen Interactions. Totowa NJ: Humana Press; 2009. pp. 245-262.
57. Brehm K. Echinococcus multilocularis as an experimental model in stem cell re-search and molecular host-parasite interaction. Parasitology 2010;137:537-555.
58. Stettler M, Fink R, Walker M, et al. In vitro parasiticidal effect of nitazoxanide against Echinococcus multilocularis metacestodes. Antimicrob Agents Chemother 2003; 47:467-474.
59. Stettler M, Rossignol JF, Fink R, et al. Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound antiparasitic activity. Int J Parasitol 2004; 34:615-624.
60. Reuter S, Merkle M, Brehm K, et al. The effect of amphotericin B on the larval growth of Echinococcus multilocularis. Antimicrob Agents Chemother 2003; 47:620-625.
61. Reuter S, Beisler T, Kern P. Combined albendazole and amphotericin B against Echinococcus multilocularis in vitro. Acta Trop 2010; 115:270-274.
62. Naguleswaran A, Spicher M, Vonlaufen N, et al. In vitro metacestodicidal activities of genistein and other isoflavones against Echinococcus multilocularis and Echinococcus granulosus. Antimicrob Agents Chemother 2006; 50:3770-3778.
63. Spicher M, Naguleswaran A, Ortega-Mora LM, et al. In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes. Exp Parasitol 2008; 119:475-482; Epub 2008 Mar 7.
64. Spicher M, Roethlisberger C, Lany C, et al. In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives. Antimicrob Agents Chemother 2008; 52:3447-3450; Epub 2008 Jul 14.
65. Reuter S, Buck A, Grebe O, et al. Salvage treatment with amphotericin B in progressive human alveolar echinococcosis. Antimicrob Agents Chemother 2003; 47:3586-3591.
66. Kern P, Abboud P, Kern W, et al. Critical appraisal of nitazoxanide for the treatment of alveolar echinococcosis. (Abstract). Am J Trop Med Hyg 2008; 79:119.
67. Tappe D, Muller A, Frosch M, Stich A. Limitations of amphotericin B and nitazoxanide in the treatment of alveolar echinococcosis. Ann Trop Med Parasitol 2009; 103:177-181.
68. Kadry Z, Renner EC, Bachmann LM, et al. Evaluation of treatment and long-term follow-up in patients with hepatic alveolar echinococcosis. Br J Surg 2005; 92:1110-1116.
69. Uchino J, Sato N, Nakajima Y, et al. Treatment. In: Uchino J, Sato N, editors. Alveolar Echinococcosis of the Liver. Sapporo, Japan: Hokkaido University School of Medicine; 1993. pp. 137-149.
70. Bresson-Hadni S, Humbert P, Paintaud G, et al. Skin localization of alveolar echinococcosis of the liver. J Am Acad Dermatol 1996; 34:873-877.
71. Kincekova J, Hrckova G, Bober J, et al. A rare case of alveolar chinococcosis in a 14-year-old child. Helminthologia 2008; 45:28-31.
72. Polanska M, Oledzka M, Nitek P, et al. Difficulties in the diagnosis and the treatment of patient in very advanced stage of alveococcosis. Experimental Clin Hepat 2008; 4:52-54.
73. Bresson-Hadni S, Delabrousse E, Blagosklonov O, et al. Imaging aspects and nonsurgical interventional treatment in human alveolar echinococcosis. Parasitol Int 2006; 55:267-272.
74. Vogel J, Görich J, Kramme E, et al. Alveolar echinococcosis of the liver: percutaneous stent therapy in Budd-Chiari syndrome. Gut 1996; 39:762-764.
75. Koch S, Bresson-Hadni S, Miguet JP, et al. Experience of liver transplantation for incurable alveolar echinococcosis: a 45 case European collaborative report. Transplantation 2003; 75:856-863.
76. Bresson-Hadni S, Koch S, Miguet JP, et al. Indications and results of liver transplantation for Echinococcus alveolar infection: an overview. Langen-becks Arch Surg 2003; 388:231-238.
77. Xia D, Yan LN, Li B, et al. Orthotopic liver transplantation for incurable alveolar echinococcosis: report of five cases from west China. Transplant Proc 2005; 37:2181-2184.
78. Li F, Yang M, Li B, etal. Initial clinical results of orthotopic liver transplantation for hepatic alveolar echinococcosis. Liver Transpl 2007; 13:924-926.
79. Haider HH, Nishida S, Selvaggi G, et al. Alveolar Echinococcosis induced liver failure: salvage by liver transplantation in an otherwise uniformly fatal disease. Clin Transplant 2008; 22:664-667; Epub 2008 Apr 23.
80. Moray G, Shahbazov R, Sevmis S, et al. Liver transplantation in management of alveolar echinococcosis: two case reports. Transplant Proc 2009; 41: 2936-2938.